Keros Therapeutics Inc (KROS)
15.22
-1.93%
Keros Therapeutics Inc (KROS) is currently trading at $15.22. This represents a loss of 1.93% from the previous session. With a market capitalization of $0.46B, KROS is a key component of the Health Care sector. Investors looking to trade KROS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade KROS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Keros Therapeutics Inc (KROS) shows a bearish trend. Analysts are watching the 15.61 level closely.
Fundamentals
Mkt Cap0.46B
P/E Ratio0.0000
Volume305,719
60-Day Technical Chart
Advanced Charting
Need more indicators for KROS? Use the world's #1 platform.
Open KROS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $15
| Metric |
KROS -1.93% |
F +1.62% |
HIMS +2.33% |
CIFR -2.98% |
|---|---|---|---|---|
| Price | $15.22 | $14.43 | $15.82 | $16.61 |
| Mkt Cap | $0.46B | $57.57B | $3.63B | $6.61B |
| - | View → | View → | View → |
Latest Headlines
Keros CEO to speak at Oppenheimer, TD Cowen and Leerink events
Stock Titan • Feb 18, 2026
Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
TradingView • Feb 18, 2026
KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026?
Yahoo Finance • Jan 15, 2026
Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26%
simplywall.st • Nov 18, 2025
Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares | KROS Stock News
Quiver Quantitative • Oct 15, 2025
● Gemini Agentic AI Analyst Insight for KROS
Market Education
- AI and the Stock Market: How Artificial Intelligence Is Driving a New Bull Run Sep 26, 2025
- The Basics of the Stock Market for Beginners Aug 25, 2023
- I don't get this Dollar Cost Averaging (DCA). Explain pls Jul 18, 2023
External Research